EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer

Mala M Parab, Pramodkumar P Gupta, Shraddha Shetty, Santosh S Chhajed, Geetanjali Shukla, Kshitij Bapat, Debjani Dasgupta, Prerona Boruah

Biotechnology Notes · 2026 · 7 · 156-167

DOI: 10.1016/j.biotno.2026.06.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Notes, 2026. Verfasst von Mala M Parab und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Bioinformatics, D Y Patil Deemed to Be University, Navi Mumbai, 400614, Maharashtra, India. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BenzanilidesChemotherapeuticEGFR-TKIC50MCF-7MTT assaySchotten-Baumann

Autor:innen und Institutionen

  • School of Biotechnology and Bioinformatics, D Y Patil Deemed to Be University, Navi Mumbai, 400614, Maharashtra, India.
  • MET Institute of Pharmacy, MET, Nashik, Maharashtra, India.

Zitieren

APA

Parab, M. M., Gupta, P. P., Shetty, S., Chhajed, S. S., Shukla, G., Bapat, K., Dasgupta, D., & Boruah, P. (2026). In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer. Biotechnology Notes, 7, 156-167. https://doi.org/10.1016/j.biotno.2026.06.002

Vancouver

Parab MM, Gupta PP, Shetty S, Chhajed SS, Shukla G, Bapat K, et al. In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer. Biotechnology Notes. 2026;7:156-167. doi:10.1016/j.biotno.2026.06.002

BibTeX
@article{Parab2026,
  author = {Parab, Mala M and Gupta, Pramodkumar P and Shetty, Shraddha and Chhajed, Santosh S and Shukla, Geetanjali and Bapat, Kshitij and Dasgupta, Debjani and Boruah, Prerona},
  title = {In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer},
  journal = {Biotechnology Notes},
  year = {2026},
  volume = {7},
  pages = {156--167},
  doi = {10.1016/j.biotno.2026.06.002}
}
Kostenlos starten →